Results from a clinical trial in Rhode Island found the technology could assist with sensory feedback needed for walking.
Healthcare Asia Magazine on MSN
Chronic pain surge boosts spinal cord stimulation market to $4.8b by 2032
This also comes as patients shift away from opioid-based treatments. The global spinal cord stimulation (SCS) devices market ...
Oral medicine subsidies for patients aged 25 or above began early this year but adults still lack public funding for ...
Symptoms of meningitis and sepsis can include a high temperature, cold hands and feet, vomiting, confusion, and muscle and ...
Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was ...
ONWARD Medical raises €40.6M in a private placement anchored by EQT Life Sciences to fund its Empower BP pivotal trial and ...
A drug developed at Case Western at Case Western Biotechnology Incubator is showing promise in helping paralyzed patients ...
Spinal translational control mechanisms regulate gene expression and nociceptive circuit sensitization during the chronic phase of neuropathic pain.
Hypnotic cognitive therapy is associated with greater reductions in chronic pain and depression than usual care in patients ...
Minoxidil and finasteride are two FDA-approved medications considered the gold standard for treating hair loss. Other treatments like low-level light therapy, PRP injections, and supplements may also ...
Salvage therapy offered renewed analgesic efficacy among patients with spinal cord stimulation, underscoring the potential of new waveforms in enhancing pain relief and improving quality of life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results